Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif

Hongyan Zhu1, Linghu Nie, Carl G Maki

  • 1Department of Radiation and Cellular Oncology, Center for Molecular Oncology, University of Chicago, Chicago, IL 60637, USA.

Insights

Cyclin-dependent kinase 2 (CDK2) activity destabilizes the cell cycle inhibitor p21, promoting its degradation. This process involves phosphorylation of p21 at serine 130 and requires specific binding motifs.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • p21 is a key inhibitor in the Cip/Kip family of cyclin-dependent kinase inhibitors.
  • Previous research suggested Cdk2 activity might degrade p21, but the mechanism remained unclear.

Purpose of the Study:

  • To elucidate the mechanism by which Cdk2 influences p21 stability and degradation.
  • To investigate the roles of specific p21 domains and phosphorylation in this process.

Main Methods:

  • Co-expression of p21 with wild-type and mutant Cdk2/cyclin E.
  • Analysis of p21 stabilization and degradation.
  • In vitro phosphorylation assays.

Main Results:

  • Cdk2 activity, not just binding, destabilizes p21.
  • Phosphorylation of p21 at Ser-130 by active Cdk2 is critical for degradation.
  • Specific cyclin-binding motifs (cy1 and cy2) in p21 are essential for these interactions.

Conclusions:

  • Active Cdk2 destabilizes p21 through phosphorylation at Ser-130, mediated by the cy2 motif.
  • This clarifies a key regulatory pathway controlling p21 levels and cell cycle progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...